Authors:
BRISTOW LJ
KRAMER MS
KULAGOWSKI J
PATEL S
RAGAN CI
SEABROOK GR
Citation: Lj. Bristow et al., SCHIZOPHRENIA AND L-745,870, A NOVEL DOPAMINE D4 RECEPTOR ANTAGONIST, Trends in pharmacological sciences, 18(6), 1997, pp. 186-188
Authors:
BRISTOW LJ
COLLINSON N
COOK GP
CURTIS N
FREEDMAN SB
KULAGOWSKI JJ
LEESON PD
PATEL S
RAGAN CI
RIDGILL M
SAYWELL KL
TRICKLEBANK MD
Citation: Lj. Bristow et al., L-745,870, A SUBTYPE-SELECTIVE DOPAMINE-D4 RECEPTOR ANTAGONIST, DOES NOT EXHIBIT A NEUROLEPTIC-LIKE PROFILE IN RODENT BEHAVIORAL-TESTS, The Journal of pharmacology and experimental therapeutics, 283(3), 1997, pp. 1256-1263
Authors:
PATEL S
FREEDMAN S
CHAPMAN KL
EMMS F
FLETCHER AE
KNOWLES M
MARWOOD R
MCALLISTER G
MYERS J
PATEL S
CURTIS N
KULAGOWSKI JJ
LEESON PD
RIDGILL M
GRAHAM M
MATHESON S
RATHBONE D
WATT AP
BRISTOW LJ
RUPNIAK NMJ
BASKIN E
LYNCH JJ
RAGAN CI
Citation: S. Patel et al., BIOLOGICAL PROFILE OF L-745,870, A SELECTIVE ANTAGONIST WITH HIGH-AFFINITY FOR THE DOPAMINE-D4 RECEPTOR, The Journal of pharmacology and experimental therapeutics, 283(2), 1997, pp. 636-647
Authors:
ROWLEY M
COLLINS I
BROUGHTON HB
DAVEY WB
BAKER R
EMMS F
MARWOOD R
PATEL S
PATEL S
RAGAN CI
FREEDMAN SB
BALL R
LEESON PD
Citation: M. Rowley et al., 4-HETEROCYCLYLPIPERIDINES AS SELECTIVE HIGH-AFFINITY LIGANDS AT THE HUMAN DOPAMINE D4 RECEPTOR, Journal of medicinal chemistry, 40(15), 1997, pp. 2374-2385
Authors:
QUIRK K
BLURTON P
FLETCHER S
LEESON P
TANG F
MELLILO D
RAGAN CI
MCKERNAN RM
Citation: K. Quirk et al., [H-3] L-655,708, A NOVEL LIGAND SELECTIVE FOR THE BENZODIAZEPINE SITEOF GABA(A) RECEPTORS WHICH CONTAIN THE ALPHA-5 SUBUNIT, Neuropharmacology, 35(9-10), 1996, pp. 1331-1335
Authors:
GRIMWOOD S
LEBOURDELLES B
ATACK JR
BARTON C
COCKETT W
COOK SM
GILBERT E
HUTSON PH
MCKERNAN RM
MYERS J
RAGAN CI
WINGROVE PB
WHITING PJ
Citation: S. Grimwood et al., GENERATION AND CHARACTERIZATION OF STABLE CELL-LINES EXPRESSING RECOMBINANT HUMAN N-METHYL-D-ASPARTATE RECEPTOR SUBTYPES, Journal of neurochemistry, 66(6), 1996, pp. 2239-2247
Citation: S. Grimwood et al., MODULATION OF CA-45(2+) INFLUX INTO CELLS STABLY EXPRESSING RECOMBINANT HUMAN NMDA RECEPTORS BY LIGANDS ACTING AT DISTINCT RECOGNITION SITES, Journal of neurochemistry, 66(6), 1996, pp. 2589-2595
Authors:
KULAGOWSKI JJ
BROUGHTON HB
CURTIS NR
MAWER IM
RIDGILL MP
BAKER R
EMMS F
FREEDMAN SB
MARWOOD R
PATEL S
PATEL S
RAGAN CI
LEESON PD
Citation: Jj. Kulagowski et al., L)PIPERAZIN-1-YL]METHYL]-1H-PYRROLO[2,3-B]PYRIDINE - AN ANTAGONIST WITH HIGH-AFFINITY AND SELECTIVITY FOR THE HUMAN DOPAMINE D-4 RECEPTOR, Journal of medicinal chemistry, 39(10), 1996, pp. 1941-1942
Authors:
ROWLEY M
BROUGHTON HB
COLLINS I
BAKER R
EMMS F
MARWOOD R
PATEL S
PATEL S
RAGAN CI
FREEDMAN SB
LEESON PD
Citation: M. Rowley et al., ETHYL-3-(1-(2-PHENYLETHYL)PIPERIDIN-4-YL)ISOXAZOLE - A POTENT, SELECTIVE ANTAGONIST AT HUMAN CLONED DOPAMINE D4 RECEPTORS, Journal of medicinal chemistry, 39(10), 1996, pp. 1943-1945
Authors:
PATEL S
PATEL S
MARWOOD R
FLETCHER AE
KULAGOWSKI J
RAGAN CI
LEESON PD
FREEDMAN SB
Citation: S. Patel et al., L-745,870 )PIPERAZIN-1-YL]METHYL)-1H-PYRROLO[2,3-B]PYRIDINE) - A HIGH-AFFINITY AND SELECTIVE DOPAMINE D4 RECEPTOR ANTAGONIST, British Journal of Pharmacology, 119, 1996, pp. 30-30
Authors:
BRISTOW LJ
SAYWELL KL
COOK GP
KULAGOWSKI JJ
LEESON PD
RAGAN CI
TRICKLEBANK MD
Citation: Lj. Bristow et al., LACK OF EFFECT OF THE DOPAMINE D-4 RECEPTOR ANTAGONIST, L-745,870 ON AMPHETAMINE-INDUCED BEHAVIORS IN RODENTS, British Journal of Pharmacology, 119, 1996, pp. 210-210
Authors:
MCKERNAN RM
WAFFORD K
QUIRK K
HADINGHAM KL
HARLEY EA
RAGAN CI
WHITING PJ
Citation: Rm. Mckernan et al., THE PHARMACOLOGY OF THE BENZODIAZEPINE SITE OF THE GABA-A RECEPTOR ISDEPENDENT ON THE TYPE OF GAMMA-SUBUNIT PRESENT, Journal of receptor and signal transduction research, 15(1-4), 1995, pp. 173-183
Authors:
SADLER IIJ
SMITH DW
SHEARMAN MS
RAGAN CI
TAILOR VJ
POLLACK SJ
Citation: Iij. Sadler et al., SULFATED COMPOUNDS ATTENUATE BETA-AMYLOID TOXICITY BY INHIBITING ITS ASSOCIATION WITH CELLS, NeuroReport, 7(1), 1995, pp. 49-53
Citation: K. Quirk et al., CHARACTERIZATION OF DELTA-SUBUNIT CONTAINING GABA(A) RECEPTORS FROM RAT-BRAIN, European journal of pharmacology. Molecular pharmacology section, 290(3), 1995, pp. 175-181
Authors:
GRIMWOOD S
GILBERT E
MYERS J
LEBOURDELLES B
COCKETT W
RAGAN CI
WHITING PJ
HUTSON PH
Citation: S. Grimwood et al., CHARACTERIZATION OF STABLY EXPRESSED RECOMBINANT HUMAN N-METHYL-D-ASPARTATE RECEPTORS USING A CA-45(2-INFLUX ASSAY()), British Journal of Pharmacology, 116, 1995, pp. 113-113
Citation: Ea. Harley et al., RELATIONSHIP BETWEEN INHIBITION OF CYCLIC-AMP PRODUCTION IN CHINESE-HAMSTER OVARY CELLS EXPRESSING THE RAT D-2(444) RECEPTOR AND ANTAGONISTAGONIST BINDING RATIOS, British Journal of Pharmacology, 115(7), 1995, pp. 1307-1313
Citation: Ms. Shearman et al., INHIBITION OF PC12 CELL REDOX ACTIVITY IS A SPECIFIC, EARLY INDICATOROF THE MECHANISM OF BETA-AMYLOID-MEDIATED CELL-DEATH, Proceedings of the National Academy of Sciences of the United Statesof America, 91(4), 1994, pp. 1470-1474
Authors:
POLLACK SJ
ATACK JR
KNOWLES MR
MCALLISTER G
RAGAN CI
BAKER R
FLETCHER SR
IVERSEN LL
BROUGHTON HB
Citation: Sj. Pollack et al., MECHANISM OF INOSITOL MONOPHOSPHATASE, THE PUTATIVE TARGET OF LITHIUM-THERAPY, Proceedings of the National Academy of Sciences of the United Statesof America, 91(13), 1994, pp. 5766-5770
Authors:
HADINGHAM KL
WINGROVE PB
WAFFORD KA
BAIN C
KEMP JA
PALMER KJ
WILSON AW
WILCOX AS
SIKELA JM
RAGAN CI
WHITING PJ
Citation: Kl. Hadingham et al., ROLE OF THE BETA-SUBUNIT IN DETERMINING THE PHARMACOLOGY OF HUMAN GAMMA-AMINOBUTYRIC-ACID TYPE-A RECEPTORS (VOL 44, PG 1211, 1993), Molecular pharmacology, 46(1), 1994, pp. 211-211
Authors:
QUIRK K
GILLARD NP
RAGAN CI
WHITING PJ
MCKERNAN RM
Citation: K. Quirk et al., GAMMA-AMINOBUTYRIC-ACID TYPE-A RECEPTORS IN THE RAT-BRAIN CAN CONTAINBOTH GAMMA-2 AND GAMMA-3 SUBUNITS, BUT GAMMA-1 DOES NOT EXIST IN COMBINATION WITH ANOTHER GAMMA-SUBUNIT, Molecular pharmacology, 45(6), 1994, pp. 1061-1070
Authors:
ATACK JR
PRIOR AM
FLETCHER SR
QUIRK K
MCKERNAN R
RAGAN CI
Citation: Jr. Atack et al., EFFECTS OF L-690,488, A PRODRUG OF THE BISPHOSPHONATE INOSITOL MONOPHOSPHATASE INHIBITOR L-690,330, ON PHOSPHATIDYLINOSITOL CYCLE MARKERS, The Journal of pharmacology and experimental therapeutics, 270(1), 1994, pp. 70-76
Authors:
QUIRK K
GILLARD NP
RAGAN CI
WHITING PJ
MCKERNAN RM
Citation: K. Quirk et al., MODEL OF SUBUNIT COMPOSITION OF GAMMA-AMINOBUTYRIC-ACID A RECEPTOR SUBTYPES EXPRESSED IN RAT CEREBELLUM WITH RESPECT TO THEIR ALPHA-SUBUNITAND GAMMA DELTA-SUBUNIT/, The Journal of biological chemistry, 269(23), 1994, pp. 16020-16028
Authors:
QUIRK K
GILLARD N
WHITING PJ
RAGAN CI
MCKERNAN RM
Citation: K. Quirk et al., STRUCTURE AND PHARMACOLOGICAL CHARACTERIZATION OF DELTA-CONTAINING GABA(A) RECEPTORS IN RAT-BRAIN, British Journal of Pharmacology, 112, 1994, pp. 210000131-210000131